Associate Professor Ron Dick is the Director of Cardiac Services Clinical Institute at Epworth HealthCare and the former Chair of Epworth’s Group Medical Advisory Council.

His specialties and interests include interventional cardiology, management of acute coronary syndrome including myocardial infarction, cardiogenic shock, clinical research and medical education.
 

Jayme is a car­dio­tho­racic sur­geon trained in adult and pae­di­atric car­diac surgery. He is cur­rent­ly Direc­tor of Car­dio­tho­racic Surgery at Flinders Med­ical Cen­tre, a Direc­tor of Ade­laide Car­dio­tho­racic, and Staff Spe­cial­ist at Women’s and Children’s Hos­pi­tal (Ade­laide) and Roy­al Dar­win Hos­pi­tal. He was recent­ly pro­mot­ed to Pro­fes­sor, Car­dio­tho­racic Surgery at Flinders University.

Jayme is the new­ly appoint­ed Clin­i­cal Lead for the Statewide Car­diac Care Clin­i­cal Net­work, at the CEIH.

Mr Marco Larobina is a consultant cardiothoracic surgeon at the Epworth Richmond Hospital, Royal Melbourne Hospital, Melbourne Private Hospital, and One Heart Cardiology. He has a special interest in adult cardiac surgery, minimally invasive surgery, adult congenital heart disease, thoracic surgery, and aortic valve surgery.

He completed his training at the Alfred Hospital, Royal Melbourne Hospital, and Royal Children’s Hospital. Following this, Marco completed a Fellowship at Papworth Hospital, Cambridge and Massachusetts General Hospital, Boston and obtained his Fellowship from Royal Australasian College of Surgeons.

disease.

Mr Peter Skillington is a specialist cardiothoracic surgeon. He also performs routine coronary artery bypass graft, heart valve and aortic surgery. 

He is Director of the Cardiothoracic Surgery Unit of the Royal Melbourne Hospital and Deputy Director of the Cardiac Sciences Clinical Institute, Epworth Hospital.

His chief research and clinical interests are aortic valve replacement utilising the ROSS procedure, for which he is a world expert, an operation which he has pioneered in this country. His other main area of interest is in adult congenital cardiac surgery, an area in which he has performed over 900 congenital cardiac surgery procedures since the 1990s. 

He has previously been President of the Australian and New Zealand Society of Cardiothoracic Surgeons (ANZSCTS), and also he has been Chairman of the Board of Studies for Cardiothoracic Surgery Training in Australia and New Zealand (RACS).

.

Alex is a cardiologist at the Austin Hospital and lead physician in the Cardio-Haematology service where she manages patients with cardiac issues who have cancer. Her other interests include women’s cardiac health and imaging for structural intervention. She has published extensively, and her manuscripts have been featured in the world’s top cardiology journals. She was recently awarded scholarships from the Cardiac Society of Australia and New Zealand, the National Health and Medical Research Council, National Heart Foundation and the Epworth Medical Research Foundation to undertake a PhD on “Cardiovascular Risk Reduction in Cancer Patients” through the University of Melbourne.

Alex has developed a smartphone based cardiovascular risk reduction program called ‘BreastMate’ aimed to care for the cardiac health of women with breast cancer. This has been rolled out in a state-wide randomised controlled trial called SMART-BREAST.

Associate Professor Neil Strathmore has expertise in pacemaker & defibrillator implantation, follow up and removal. However, he is also interested in arrhythmias, valve problems, heart failure and general cardiology. He is widely recognised as a leading teacher of medical students.

A/Prof Monique Watts is a heart failure cardiologist and specialist in women’s heart disease who works at Epworth Freemasons and the Alfred.

Dr Watts completed advanced training at the Royal Melbourne Hospital before undertaking a fellowship in advanced heart failure and transplantation at the Alfred Hospital. Dr Watts manages patients with all types of heart failure in both the inpatient and outpatient setting. In recent years Dr Watts has also established a cardiac clinic in North Central Victoria to improve access to specialist care for rural citizens. Dr Watts has also lead the development of the Women’s Heart Clinic at the Alfred Hospital which offers specialised care for patients suffering conditions more commonly seen in women such as the syndrome of MINOCA and contributory causes such as coronary artery vasospasm, spontaneous coronary artery dissection and microvascular dysfunction. Dr Watts is actively involved in clinical research, with multiple current projects in progress in the area of women’s heart disease. She also teaches for the University of Melbourne Clinical School.

Dr Johns has worked at the Austin Hospital since 1987 and at Epworth since 1984. Her main interests are echocardiography, management of valve disease and management of heart disease in pregnancy.

She is the Cardiologist appointed to the Perinatal Unit at Mercy Hospital for Women. The Unit provides multi-disciplinary management of pregnancy in women with heart disease. 

Dr Johns was awarded an AM in 2015, for services to cardiology as a clinician, teacher and mentor and for service to the not-for-profit sector.

Alex is a cardiologist at the Austin Hospital and lead physician in the Cardio-Haematology service where she manages patients with cardiac issues who have cancer. Her other interests include women’s cardiac health and imaging for structural intervention. She has published extensively, and her manuscripts have been featured in the world’s top cardiology journals. She was recently awarded scholarships from the Cardiac Society of Australia and New Zealand, the National Health and Medical Research Council, National Heart Foundation and the Epworth Medical Research Foundation to undertake a PhD on “Cardiovascular Risk Reduction in Cancer Patients” through the University of Melbourne.

Alex has developed a smartphone based cardiovascular risk reduction program called ‘BreastMate’ aimed to care for the cardiac health of women with breast cancer. This has been rolled out in a state-wide randomised controlled trial called SMART-BREAST.